WaldenstroM Macroglobulinaemia: The Key Questions

Anita D'Souza; Stephen Ansell; Craig Reeder; Morie A. Gertz

doi:10.1111/bjh.12367

WaldenstroM Macroglobulinaemia: The Key Questions

Anita D'Souza, Stephen Ansell, Craig Reeder, Morie A. Gertz

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Abstract

In this review, the key issues that pertain to Waldenström disease are discussed in a concise question-and-answer format. Diagnosis, prognosis, and indications for state-of-the-art therapy are updated. Current therapies presented at the 7th International Workshop for Waldenström Macroglobulinaemia are included.

Original language	English (US)
Pages (from-to)	295-303
Number of pages	9
Journal	British journal of haematology
Volume	162
Issue number	3
DOIs	https://doi.org/10.1111/bjh.12367
State	Published - Aug 2013

Keywords

Hyperviscosity
IgM monoclonal proteins
Lymphoplasmacytic lymphoma
Stem cell transplant
Waldenström macroglobulinaemia

ASJC Scopus subject areas

Hematology

Access to Document

10.1111/bjh.12367

Cite this

@article{d0bc94d0f40d4d208e1b3d4b595dde76,

title = "WaldenstroM Macroglobulinaemia: The Key Questions",

abstract = "In this review, the key issues that pertain to Waldenstr{\"o}m disease are discussed in a concise question-and-answer format. Diagnosis, prognosis, and indications for state-of-the-art therapy are updated. Current therapies presented at the 7th International Workshop for Waldenstr{\"o}m Macroglobulinaemia are included.",

keywords = "Hyperviscosity, IgM monoclonal proteins, Lymphoplasmacytic lymphoma, Stem cell transplant, Waldenstr{\"o}m macroglobulinaemia",

author = "Anita D'Souza and Stephen Ansell and Craig Reeder and Gertz, {Morie A.}",

year = "2013",

month = aug,

doi = "10.1111/bjh.12367",

language = "English (US)",

volume = "162",

pages = "295--303",

journal = "British journal of haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - WaldenstroM Macroglobulinaemia

T2 - The Key Questions

AU - D'Souza, Anita

AU - Ansell, Stephen

AU - Reeder, Craig

AU - Gertz, Morie A.

PY - 2013/8

Y1 - 2013/8

N2 - In this review, the key issues that pertain to Waldenström disease are discussed in a concise question-and-answer format. Diagnosis, prognosis, and indications for state-of-the-art therapy are updated. Current therapies presented at the 7th International Workshop for Waldenström Macroglobulinaemia are included.

AB - In this review, the key issues that pertain to Waldenström disease are discussed in a concise question-and-answer format. Diagnosis, prognosis, and indications for state-of-the-art therapy are updated. Current therapies presented at the 7th International Workshop for Waldenström Macroglobulinaemia are included.

KW - Hyperviscosity

KW - IgM monoclonal proteins

KW - Lymphoplasmacytic lymphoma

KW - Stem cell transplant

KW - Waldenström macroglobulinaemia

UR - http://www.scopus.com/inward/record.url?scp=84880275386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880275386&partnerID=8YFLogxK

U2 - 10.1111/bjh.12367

DO - 10.1111/bjh.12367

M3 - Review article

C2 - 23651417

AN - SCOPUS:84880275386

SN - 0007-1048

VL - 162

SP - 295

EP - 303

JO - British journal of haematology

JF - British journal of haematology

IS - 3

ER -

WaldenstroM Macroglobulinaemia: The Key Questions

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this